JPX : 7575.T

Japan Lifeline Co., Ltd.

$1570 JPY

$118 (8.13%)

Volume
633.2K
Average Volume
196.1K
Market Capitalization
$110.14B
P/E Ratio
11.77
Dividend Yield
3.44%
Price Target
Year High
$1645.00
Year Low
$1239.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.17
Company Overview

JPX

Keisuke Suzuki

Medical - Devices

Healthcare

7575.T

1304

JP

JPY

https://www.japanlifeline.com

81 3 6711 5200

N/A

N/A

Liquidity Metrics

0.06

4.17

2.40

0.85

0.00

Sales & Valuation

$59.19B

1.82

1.71

0.00

0.00

Profitability

$133.28

$9.35B

15.47%

20.56%

14.70%

12.21%

P/E Metrics

11.77

16.07

16.07

Analyst Price Target & Rating

Strong Buy

5/5

0 Analysts

%

Financial Health Scores

3/9

$36.06B

$76.62B

-$

$11.58B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Yoshiaki Ikei Independent Outside Director
Tatsuya Murase Vice President, Chief Operating Officer & Representative Director
Toru Takamiya Senior Executive Officer, Head of R&D and Production Group & Director
Naohiro Nakada Senior Operating Officer & Deputy Head of Arrhythmia Business Operations Group
Toshihiro Miyake Executive Officer and General Manager of RA Division R & D & Production Group
Takeyoshi Egawa Director, Executive Officer, CFO & Head of Corporate Management Group
Keisuke Suzuki President, Chief Executive Officer & Representative Director
KuNobuo Takahashi Senior Operating Officer & Head of Global Business Development Group
Yumiko Hoshiba Director, Senior Operating Officer & GM of Operations Division of Corporate Administration Group
Kenji Yamada Director, Executive Officer & Head of Corporate Administration Group
Takashi Ito Executive Officer, Head of Arrhythmia Business Operations Group & Director
Poll Results

No votes yet today — be the first to share your view!

About Japan Lifeline Co., Ltd. (JPX:7575.T) Stock

Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal tempera ... ture monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.

Frequently Asked Questions

What is the current Japan Lifeline Co., Ltd. (7575.T) stock price?

Japan Lifeline Co., Ltd.(JPX:7575.T) stock price is $1570 in the last trading session. During the trading session, 7575.T stock reached the peak price of $1645 while $1239 was the lowest point it dropped to. The percentage change in 7575.T stock occurred in the recent session was 8.13% while the dollar amount for the price change in 7575.T stock was $118.

7575.T's industry and sector of operation?

The JPX listed 7575.T is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of 7575.T?

Yoshiaki Ikei | Independent Outside Director
Tatsuya Murase | Vice President, Chief Operating Officer & Representative Director
Toru Takamiya | Senior Executive Officer, Head of R&D and Production Group & Director
Naohiro Nakada | Senior Operating Officer & Deputy Head of Arrhythmia Business Operations Group
Toshihiro Miyake | Executive Officer and General Manager of RA Division R & D & Production Group

How many employees does 7575.T have?

Number of 7575.T employees currently stands at 1304. 7575.T operates from Tennoz Ocean Square, Tokyo, TY 140-0002, JP.

Link for 7575.T official website?

Official Website of 7575.T is: https://www.japanlifeline.com

How do I contact 7575.T?

7575.T could be contacted at phone #81 3 6711 5200 and can also be accessed through its website. 7575.T operates from Tennoz Ocean Square, Tokyo, TY 140-0002, JP.

How many shares of 7575.T are traded daily?

The average number of 7575.T shares traded daily for last 3 months was 196.1K.

What is the market cap of 7575.T currently?

The market value of 7575.T currently stands at $110.14B with its latest stock price at $1570